OPX Biotechnologies: Series A $3.6M
by Adam Rubenstein
CLSDF
OPX Biotechnologies (Boulder, Colorado) announced the close of a $3.6M Series A financing led by Mohr Davidow Ventures and X/Seed Capital Management.
OPX is enabling renewable fuels and chemicals that are economically and environmentally superior to petroleum-based products by using a pioneering technology platform known as SCALEs to enable massively parallel full genome search and modification to rapidly optimize the microbes used for producing biofuels and biorefined chemicals. The goal is to vastly decrease production costs and capital requirements, thus removing one of the major barriers to the use of renewable fuels and chemicals.
Colorado Life Science Deal Flow (CLSDF) is a regular contributor to BioHealth Investor
_____________
CLSDF
OPX Biotechnologies (Boulder, Colorado) announced the close of a $3.6M Series A financing led by Mohr Davidow Ventures and X/Seed Capital Management.
OPX is enabling renewable fuels and chemicals that are economically and environmentally superior to petroleum-based products by using a pioneering technology platform known as SCALEs to enable massively parallel full genome search and modification to rapidly optimize the microbes used for producing biofuels and biorefined chemicals. The goal is to vastly decrease production costs and capital requirements, thus removing one of the major barriers to the use of renewable fuels and chemicals.
Colorado Life Science Deal Flow (CLSDF) is a regular contributor to BioHealth Investor
_____________
posted by Nico at
5:30 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home